Epista Life Science A/S — Credit Rating and Financial Key Figures
CVR number: 32141064
Slotsmarken 17, 2970 Hørsholm
info@epista.com
tel: 48254500
www.epista.com
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | 53 736.26 | 79 704.93 | |||
Employee benefit expenses | -50 909.19 | -68 756.95 | |||
Other operating expenses | - 193.15 | ||||
Total depreciation | - 208.58 | -1 126.86 | |||
EBIT | 2 844.00 | 4 658.00 | 7 349.00 | 2 618.48 | 9 627.97 |
Other financial income | 134.76 | 304.72 | |||
Other financial expenses | - 385.28 | - 975.54 | |||
Net income from associates (fin.) | 3 079.83 | 3 511.74 | |||
Pre-tax profit | 3 372.00 | 3 967.00 | 9 106.00 | 5 447.79 | 12 468.89 |
Income taxes | - 549.48 | -1 971.83 | |||
Net earnings | 3 372.00 | 3 967.00 | 9 106.00 | 4 898.32 | 10 497.06 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Goodwill | 4 053.40 | 3 844.64 | |||
Intangible assets total | 4 053.40 | 3 844.64 | |||
Buildings | 129.69 | 46.83 | |||
Machinery and equipment | 7.23 | 4 377.56 | |||
Tangible assets total | 136.93 | 4 424.39 | |||
Holdings in group member companies | 13 561.40 | 22 952.83 | |||
Investments total | 15 303.00 | 24 168.00 | 25 191.00 | 14 376.66 | 23 842.17 |
Non-curr. owed by group member comp. | 12 299.87 | 7 148.35 | |||
Long term receivables total | 12 299.87 | 7 148.35 | |||
Inventories total | |||||
Current trade debtors | 13 411.52 | 23 959.18 | |||
Current amounts owed by group member comp. | 3 068.73 | 1 630.61 | |||
Prepayments and accrued income | 435.01 | 1 075.21 | |||
Current other receivables | 58.07 | 319.38 | |||
Short term receivables total | 16 973.33 | 26 984.39 | |||
Cash and bank deposits | 7 543.14 | 15 093.85 | |||
Cash and cash equivalents | 7 543.14 | 15 093.85 | |||
Balance sheet total (assets) | 15 303.00 | 24 168.00 | 25 191.00 | 55 383.34 | 81 337.79 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Share capital | 6 573.00 | 8 587.00 | 14 662.00 | 524.35 | 524.35 |
Other reserves | 4 059.42 | 8 299.53 | |||
Retained earnings | -3 372.00 | -3 967.00 | -9 106.00 | 18 433.55 | 19 683.51 |
Profit of the financial year | 3 372.00 | 3 967.00 | 9 106.00 | 4 898.32 | 10 497.06 |
Shareholders equity total | 6 573.00 | 8 587.00 | 14 662.00 | 27 915.64 | 39 004.45 |
Provisions | 887.81 | 884.68 | |||
Non-current leasing loans | 1 810.81 | ||||
Non-current liabilities total | 1 810.81 | ||||
Current loans from credit institutions | 1.00 | 1 932.99 | |||
Advances received | 0.03 | 1 054.17 | |||
Current trade creditors | 2 000.25 | 6 416.06 | |||
Current owed to group member | 11 424.23 | 12 321.77 | |||
Short-term deferred tax liabilities | 208.11 | 1 974.96 | |||
Other non-interest bearing current liabilities | 12 946.26 | 15 937.90 | |||
Current liabilities total | 26 579.89 | 39 637.86 | |||
Balance sheet total (liabilities) | 6 573.00 | 8 587.00 | 14 662.00 | 55 383.34 | 81 337.79 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.